171
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Schisandrin B inhibits TGF-β1-induced epithelial-mesenchymal transition in human A549 cells through epigenetic silencing of ZEB1

, , , , , & show all
Pages 157-166 | Received 10 Nov 2018, Accepted 06 Jun 2019, Published online: 03 Jul 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hasan Badibostan, Nastaran Eizadi-Mood, A. Wallace Hayes & Gholamreza Karimi. (2024) Protective effects of natural compounds against paraquat-induced pulmonary toxicity: the role of the Nrf2/ARE signaling pathway. International Journal of Environmental Health Research 34:1, pages 611-624.
Read now

Articles from other publishers (17)

Margherita Sisto & Sabrina Lisi. (2024) Epigenetic Regulation of EMP/EMT-Dependent Fibrosis. International Journal of Molecular Sciences 25:5, pages 2775.
Crossref
Jiajun Pan, Yichen Jiang, Yuanyuan Huang, Haiying Zhang, Xi Wang, Chao Luo, Hui Wang, Miao Tang, Gang Pei & Qun Tang. (2023) Liuwei Dihuang Decoction Drug-containing Serum Attenuates Transforming Growth Factor-β1-induced Epithelial-mesenchymal Transition in HK-2 Cells by Inhibiting NF-κB/Snail Signaling Pathway. Current Pharmaceutical Biotechnology 24:12, pages 1589-1602.
Crossref
Xian-Chen Wang, Kai Song, Bin Tu, He Sun, Yang Zhou, Sheng-Song Xu, Dong Lu, Ji-Ming Sha & Hui Tao. (2023) New aspects of the epigenetic regulation of EMT related to pulmonary fibrosis. European Journal of Pharmacology 956, pages 175959.
Crossref
Liqin Zhou, Liping Zhou, Huanjie Ma, Jinkai Zhao & Dayong Lou. (2023) Schisandrin B Inhibits Osteosarcoma Cell Proliferation and Promotes Apoptosis Through PI3K/AKT/mTOR Pathway Mediated Autophagy. Revista Brasileira de Farmacognosia 33:5, pages 945-953.
Crossref
TIANZHU LI, YU ZHANG, TONG ZHANG, YANNAN LI, HUI XUE, JINGLONG CAO, WENSHUANG HOU, YINGHUA LUO & CHENGHAO JIN. (2023) Schisandrin B exerts anticancer effects on human gastric cancer cells through ROS-mediated MAPK, STAT3, and NF-κB pathways. BIOCELL 47:1, pages 195-204.
Crossref
Miso Park, Keon Wook Kang & Ji Won Kim. (2023) The role and application of transcriptional repressors in cancer treatment. Archives of Pharmacal Research 46:1, pages 1-17.
Crossref
Zhenghua Wu, Mengqi Jia, Wenjuan Zhao, Xucong Huang, Xinyi Yang, Dongxin Chen, Xijier Qiaolongbatu, Xiaojing Li, Jiaqi Wu, Feng Qian, Yuefen Lou & Guorong Fan. (2022) Schisandrol A, the main active ingredient of Schisandrae Chinensis Fructus, inhibits pulmonary fibrosis through suppression of the TGF-β signaling pathway as revealed by UPLC-Q-TOF/MS, network pharmacology and experimental verification. Journal of Ethnopharmacology 289, pages 115031.
Crossref
Mingwei Zhu, Jiamei Niu, Jian Jiang, Tianxiu Dong, Yaodong Chen, Xiuhua Yang & Pengfei Liu. (2022) Chelerythrine inhibits the progression of glioblastoma by suppressing the TGFB1-ERK1/2/Smad2/3-Snail/ZEB1 signaling pathway. Life Sciences 293, pages 120358.
Crossref
Varalakshmi Velagacherla, Chetan Hasmukh Mehta, Yogendra Nayak & Usha Yogendra Nayak. (2022) Molecular pathways and role of epigenetics in the idiopathic pulmonary fibrosis. Life Sciences 291, pages 120283.
Crossref
Mingjie Wang, Yan Sun, Cheng Li, Jing Qu & Bing Zhou. (2022) Eosinophils Correlate with Epithelial-Mesenchymal Transition in Chronic Rhinosinusitis with Nasal Polyps. ORL 84:1, pages 70-80.
Crossref
Tiantian Liu, Pengli Xu, Shaorui Ke, Haoran Dong, Mengmeng Zhan, Qin Hu & Jiansheng Li. (2022) Histone methyltransferase SETDB1 inhibits TGF-β-induced epithelial–mesenchymal transition in pulmonary fibrosis by regulating SNAI1 expression and the ferroptosis signaling pathway. Archives of Biochemistry and Biophysics 715, pages 109087.
Crossref
Syeda Saniya Zahra, Ihsan-ul Haq & Omer Farooq. 2022. Nutraceuticals and Health Care. Nutraceuticals and Health Care 61 85 .
Tihong Shao, Xiaodong Shi, Shanpeng Yang, Wei Zhang, Xiaohu Li, Jingwei Shu, Shehabaldin Alqalyoobi, Amir A. Zeki, Patrick S. Leung & Zongwen Shuai. (2021) Interstitial Lung Disease in Connective Tissue Disease: A Common Lesion With Heterogeneous Mechanisms and Treatment Considerations. Frontiers in Immunology 12.
Crossref
Krystian Bartczak, Adam J. Białas, Mateusz J. Kotecki, Paweł Górski & Wojciech J. Piotrowski. (2020) More than a Genetic Code: Epigenetics of Lung Fibrosis. Molecular Diagnosis & Therapy 24:6, pages 665-681.
Crossref
Kamil Kiełbasiński, Wojciech Peszek, Beniamin O. Grabarek, Dariusz Boroń, Magdalena Wierzbik-Strońska & Marcin Oplawski. (2020) Effect of Salinomycin on Expression Pattern of Genes Associated with Apoptosis in Endometrial Cancer Cell Line. Current Pharmaceutical Biotechnology 21:12, pages 1269-1277.
Crossref
Milad Ashrafizadeh, Hui Li Ang, Ebrahim Rahmani Moghadam, Shima Mohammadi, Vahideh Zarrin, Kiavash Hushmandi, Saeed Samarghandian, Ali Zarrabi, Masoud Najafi, Reza Mohammadinejad & Alan Prem Kumar. (2020) MicroRNAs and Their Influence on the ZEB Family: Mechanistic Aspects and Therapeutic Applications in Cancer Therapy. Biomolecules 10:7, pages 1040.
Crossref
Andy Wai Kan Yeung, Nikolay T. Tzvetkov, Aneliya A. Balacheva, Maya G. Georgieva, Ren-You Gan, Artur Jozwik, Bożena Pyzel, Jarosław O. Horbańczuk, Ettore Novellino, Alessandra Durazzo, Massimo Lucarini, Emanuela Camilli, Eliana B. Souto, Atanas G. Atanasov & Antonello Santini. (2020) Lignans: Quantitative Analysis of the Research Literature. Frontiers in Pharmacology 11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.